Oxytocin may inhibit social phobia

Published 2008-07-20 00:00. Updated 2016-05-02 16:42Denna sida på svenska

Swedish and British scientists have shown using functional magnetic resonance imaging (fMRI) that the hormone oxytocin can inhibit feelings of anxiety in specific individuals. Their discovery might lead to a better understanding and the improved treatment of psychiatric affections in which people feel distressed when meeting others, such as in cases of autism and social phobia.

Oxytocin is a neuropeptide that is secreted by the body during massage, childbirth and breastfeeding to induce a calming, analgesic effect. Animal studies have also shown that oxytocin promotes social interaction, such as during the courting process. The hormone has a direct influence on the amygdala, a brain area that is important for social interaction and for identifying immediate emotional threats. In a new study published in the Journal of Neuroscience, scientists at the Swedish medical university Karolinska Institutet and the Welcome Trust Functional Imaging Laboratory in London show that oxytocin has a more targeted effect than simply producing a general feeling of wellbeing.

Subjects were shown pictures of four different faces, two of which were combined with a tiny, harmless but uncomfortable electric shock. As expected, the scientists found that the faces associated with the shock were considered more unpleasant than the others. However, when half of the subjects were then given oxytocin spray and the other half a placebo spray, an interesting change was brought about:

"When we showed the oxytocin group the two faces again that had previously been associated with the shock, they no longer found them disagreeable, while those who had received the placebo still found them so," says Dr Predrag Petrovic from the Department of Clinical Neuroscience at Karolinska Institutet.

Feelings of anxiety

Using an fMR scanner, the team also found that subjects who had developed shock-induced feelings of anxiety for certain faces exhibited, when shown these faces, higher levels of activity in two brain areas  the amygdale and the fusiform face area  that process unpleasant and threatening faces. These activity levels then dropped when they were given oxytocin, but not when given the placebo.

"This suggests that oxytocin can reduce anxiety and increase the chances of social contact for people with certain types of psychiatric disorder. There are also previous studies to show that oxytocin can inhibit amygdala activity, which tells us that we should see this as an opportunity for new forms of treatment," says Dr Petrovic.

Funding: The study was conducted at the Welcome Trust Functional Imaging Laboratory in London and the data analysed in London and at Karolinska Institutet in Stockholm. The study was co-financed by the Swedish Research Council.


Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity.
Petrovic P, Kalisch R, Singer T, Dolan R
J. Neurosci. 2008 Jun;28(26):6607-15

Clinical NeurosciencePsychiatric disorders